By proceeding, you agree to our Terms of Use and Privacy Policy.
Welcome to the 3rd Inner Ear Disorders Therapeutics Summit, where we aim to accelerate the development of drug-based treatments for inner ear disorders. The industry has seen progress with multiple INDs approved in recent months and interest from big pharma in acquiring innovative biotechs working on hearing loss. However, the inner ear disorder space has also faced multiple clinical failures, highlighting the need for collaboration to overcome the specific obstacles hindering late-stage clinical trials and approval.This summit brings together the community to share case studies and data-driven insights on optimizing preclinical programs and designing translational studies to validate clinically relevant targets. We will leverage the latest biotech and academic innovations, along with the experience of big pharma, to address technical and strategic challenges in delivering safe and effective therapies for the inner ear.
Discover the current tools to accelerate the advancement of hearing disorder therapeutics.
Leverage the advantages of understanding the gene therapy delivered to the inner ear., platform delivery system, inner ear therapeutics and more.
Attend Interactive workshops and sessions on optimizing clinical trial design, working with regulatory bodies, and understanding clinical endpoints.
Benefit from the guidance of seasoned industry veterans and address the strategic challenges in delivering safe and effective therapy to the inner ear.
Hanson Wade gives people the clarity to see where opportunity lies. We work in highly specialised fields to provide unmatched depth and quality of content. We work in sectors where quality of information is the difference between success and failure.
CILcare is an R&D services company specialized in hearing disorders.
ENT Clinical is the academic clinical research organisation with the know-how and expertise to support your clinical development program in the hearing field.
Turner Scientific is a company with a dual, yet related, focus.
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.